📰 Research Early Development News
Page 2 - Research Early Development News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Research Early Development. Real-time updates on events, politics, business and more.
June 2, 2022
Investegate announcements from https://immatics.com/, Immatics and Bristol Myers Squibb Expand Strategic Alliance to Develop Gamma Delta Allogeneic Cell Therapy Programs
May 12, 2022
BridgeBio Announces Exclusive License Agreement with Bristol Myers Squibb to Develop and Commercialize BBP-398, a Potentially Best-in-Class SHP2 Inhibitor, in Oncology - read this article along with other careers information, tips and advice on BioSpace
March 24, 2022
Press release content from Business Wire. The AP news staff was not involved in its creation.
March 8, 2022
Southfield, MI (PRWEB) March 08, 2022 -- Mr. Hadad is currently Chief Intellectual Property Counsel as well as lead counsel to the Research & Early
March 1, 2022
/PRNewswire/ -- Dragonfly Therapeutics, Inc. ("Dragonfly") today announced the achievement of a Phase 1 clinical development milestone for the...
March 1, 2022
Dragonfly receives a milestone payment from Bristol Myers Squibb for progression of its Phase 1 DF6002-001 study with a PK profile and peripheral PD consistent with preclinical models WALTHAM
March 1, 2022
/PRNewswire/ -- Dragonfly Therapeutics, Inc. ("Dragonfly") today announced the achievement of a Phase 1 clinical development milestone for the...
January 10, 2022
Collaboration brings together Century’s industry leading iPSC-derived allogeneic cell therapy platform with Bristol Myers Squibb’s expertise in cell therapy and oncology drug developmentFirst two programs include a program in acute myeloid leukemia and a program in multiple myeloma, which could incorporate either th...
October 7, 2021
Two African American bio-scientists selected for groundbreaking fellowship program in the life sciences...
September 22, 2021
Investegate announcements from DeepMatter Group PLC, Half Year Results